Company news
Innoveren Scientific Inc. (OTC:IVRN) news
Innoveren Scientific Inc. news releases on 6ix. Latest, Oct 3, 2023: Innoveren Scientific Divests Device & Receives Capital Infusion
Press releases & updates
Innoveren Scientific Divests Device & Receives Capital Infusion
October 2, 2023
H-CYTE Completes Acquisition of SkinDisc™ Regenerative Tissue Kit from Scion Solutions, LLC
December 29, 2022
H-CYTE Announces Intent to Acquire SkinDisc, Expects to Complete Within 30 Days
September 19, 2022
H-CYTE Completes Acquisition of Jantibody
September 8, 2022
H-CYTE to Expect the Completed Acquisition of Jantibody Within 30 Days
July 22, 2022
H-CYTE Announces Proceeds of $1.05 Million from Warrant Exercise
March 4, 2022
H-CYTE Enters Into Letter of Intent for Acquisition of Catheter Precision, Inc.
January 11, 2022
H-CYTE Names Michael Yurkowsky Chief Executive Officer
December 6, 2021
H-CYTE Combines Clinical Outcomes and Scientific Development to Launch New Centers for Respiratory Health
September 8, 2021
H-CYTE Announces Publication of Additional Data that Further Supports Efficacy of Innovative PRP-PBMC Treatment Aimed at Helping to Improve Overall Lung Health
July 6, 2021
H-CYTE Announces Publication of Positive Real-World Data Relating to the Use of Innovative Treatment (PRP-PBMC) Aimed at Helping Improve Overall Lung Health
June 29, 2021
Robert Greif named Chief Executive Officer of H-CYTE
September 29, 2020
H-CYTE Extends Rights Offering to 5:00 PM Eastern Time on Friday, September 11, 2020
September 3, 2020
H-CYTE Issues Letter to Shareholders
January 21, 2020
H-CYTE Raises $6 Million to Accelerate FDA Approval Process of Next Generation Cellular Therapy for COPD
November 18, 2019
H-CYTE Bolsters Board of Directors With Appointment of Dr. Atta Behfar to its Board of Directors
July 30, 2019
H-CYTE Bolsters Board of Directors With Appointment of Dr. Andre Terzic to Board of Directors
July 29, 2019
H-CTYE Comments on Recent Promotional Activity
July 16, 2019
Medovex Corporation Announces Name Change to H-CYTE and New Ticker Symbol
July 12, 2019
Medovex Corporation Updates Name Change and Full Rebranding to H-CYTE
July 1, 2019
Medovex’s Transition to H-CYTE Underscores Biotechnology Focus
June 24, 2019
Medovex Corporation Announces Recent Management Appointments
April 29, 2019
Medovex Corporation Closes Financing for a Total $7.2M Under Existing Securities Purchase Agreement
April 8, 2019
Medovex Corporation Receives an Additional $1.25 Million Under Existing Securities Purchase Agreement
March 18, 2019
Medovex Corporation Announces Name Change and Full Rebranding to Blue Zone Health
February 4, 2019
Medovex Corporation Receives an Additional $2.9 Million Under Existing Securities Purchase Agreement
January 28, 2019
Medovex Corporation Enters into Securities Purchase Agreement
January 16, 2019
Medovex Corporation Announces New Board Appointments
January 15, 2019
Medovex Corporation Closes Acquisition of Pulmonary Biomedical Services and Patient Delivery Platform of Regenerative Medicine Solutions, LLC
January 14, 2019
Medovex Corporation Announces Definitive Agreement to Acquire the Pulmonary Biomedical Services and Patient Delivery Platform of Regenerative Medicine Solutions, LLC
October 16, 2018
Medovex Corporation Names William E. Horne Chief Executive Officer and Chairman of the Board
October 9, 2018
Medovex Corporation Receives ISO 13485:2016 Certification
September 25, 2018
Medovex Corporation’s DenerveX System Demonstrates Clinical Benefits in Patients Suffering from Low Back Facet Joint Pain
July 2, 2018
Medovex Corporation Announces Columbia Regulatory Approval and Issuance of Two New US Patent Approvals
April 5, 2018
Medovex Corporation Presents Initial Data on the DenerveX® System During NSpine 2nd Platinum Course in Arosa, Switzerland
February 13, 2018
Medovex Corporation Converts IDE Submission to a Pre-Submission with Food and Drug Administration for its DenerveX System
December 29, 2017
Medovex Corporation Submits IDE with the Food and Drug Administration for its DenerveX System
November 27, 2017
Medovex Corporation to Present at the 10th Annual LD Micro Main Event
November 20, 2017
Medovex Corporation Releases Letter to Shareholders
November 20, 2017
OTC Markets Group Welcomes New OTCQB Companies – November 16
November 16, 2017